EP05B-025 INFLOW MODULATION IN LIVING DONOR LIVER TRANSPLANT TO REDUCE SMALL FOR SIZE SYNDROME
X. S. Ling 1 , Y. X. Koh 2 , S. Y. Lee 2 , B. K. P. Goh 2 , P. C. Cheow 2 , A. Y. F. Chung 2 , C. Y. Chan 2 and P. Raj 2 1 Singhealth Residency, and 2 Singapore General Hospital, Singapore Introduction: Living Donor Liver Transplantation (LDLT) is the major modality for liver transplantation in Asia. A major consideration is the balance of graft size that can be safely removed from the donor without morbidity versus the graft size sufficiency in the recipient. A smaller graft size relative to the recipient body weight presents a greater relative risk in developing small-for-size (SFS) graft syndrome. We report our local experience with inflow modulation for adult living donor liver transplantation. Method: We reviewed 4 cases of adult LDLT with GWR <0.8 cases with inflow modulation using temporary hemiportocaval shunt (HPCS) and splenectomy in our institutions. Intra-operative portal pressure was measured with a catheter inserted directly into the recipient's portal vein before and after all anastomosis had been completed and clamps have been removed. The HPCS is taken down upon completion of the portal venous anastomosis. Primary outcome is defined as absence or presence of SFSS in first postoperative week. Result: All 4 patients had a right lobe graft with a GWR of <0.8. Inflow modulation with a temporary PCS and splenectomy was performed in all patients. No patients suffered from SFSS, or developed ascites. Conclusion: Creation of a temporary HPCS and splenectomy is a safe and effective as a method of inflow modulation in LDLT with GWR <0.8, with no patients developing SFSS or ascites. Milan criteria, subgroup analysis for risk factors of recurrence was performed. Results: The 1-, 3-, 5-year OS of within Milan (WM) group and beyond Milan (BM) group were 95.7%, 88%, 85.8% and 68.3%, 65.9%, 65.9%, respectively (P < 0.0001). Overall survival rate was better in the WM group than BM group [hazard ratio (HR) 2.25, 95% confidence interval (CI) 1.52-3.32, P < 0.0001]. The 1-, 3-, 5-year RFS in WM group were better than in BM group (91.8%, 87.5%, 86.1% vs. 92.3%, 58.3%, 56.3%; HR 3.89, 95% CI 2.59-5.85, P < 0.0001). In subgroup analysis of WM group, the alpha-fetoprotein (AFP) (>400 ng/mL) was only significant risk factor for recurrence after LDLT (HR 2.95, 95% CI 1.23-7.07, P = 0.015). Regarding BM group, body mass index (<21.7kg/m 2 ), platelet count, and AFP (>400 ng/mL) predicted recurrence at multivariable analysis (P = 0.038, 0.0001, and < 0.0001, respectively). Conclusions: Milan criteria can predict the prognosis of patients after LDLT for HCC. The risk factors associated with recurrence of HCC may be different according to Milan criteria.
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EP05B-028 TWO TO TANGO e A CASE FOR DUAL LOBE LIVER TRANSPLANTATION
N. Mehta, S. Mehrotra, S. Lalwani, V. Mangla and S. Nundy Department of Surgical Gastroenterology, HPB and Liver Transplantation, Sir Ganga Ram Hospital, India Introduction: Dual lobe liver transplant is technically challenging and infrequently done across the globe. Patients and methods: We prospectively collected data of 3 patients with end stage liver disease who underwent dual lobe living donor liver transplant at our institute. Results: Dual lobe transplant was done in 3 patients with mean age of 54 years (46e58) of which 2 were male and one was female. Mean GRWR with single liver was 0.61 and was considered inadequate for patients with Child C status. Mean GRWR expected with Dual Lobe was 0.85(0.83e0.87). Types of grafts used e right lobe with left lateral graft in one, right lobe with left lobe graft in another and both left lobes were used as graft in the third patient. Autologous vein graft was used for reconstructing the MHV in 2 patients with right lobe while in twin left lobes a PTFE graft was used as extension. Biliary construction was done using a combination of duct to duct and Roux en Y hepaticojejunostomy in all patients. The mean operating time was 1060 minutes. Both the lobes of liver were implanted sequentially thereby reducing the Cold Ischemia for all the liver grafts. Mean hospital stay of 18 days. There was no major donor morbidity and mortality. Median follow up at 18 months, one recipeint had biliary stenosis requiring percutaneous biliary stenting, all donors are doing well. Conclusion: Dual lobe liver transplantation, though technically a complex procedure, can be safely performed in an experienced centre with good outcome. HPB 2018, 20 (S2), S784eS826
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